Search

everythinglearnresearchcommunity

for

Search:↓

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Tamoxifen effectively treats gynecomastia without causing impotence.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Mutations in certain receptors can cause diseases and offer new treatment options.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Older men with lower levels of available testosterone are more likely to be frail.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.